Dillon & Associates’s Core Laboratories CLB Stock Holding History

Dillon & Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,450	Closed	-$516K	–	66
2018 Q3	$516K	Hold	4,450	–	–	0.17%	50
2018 Q2	$561K	Hold	4,450	–	–	0.21%	50
2018 Q1	$481K	Hold	4,450	–	–	0.19%	52
2017 Q4	$490K	Hold	4,450	–	–	0.18%	53
2017 Q3	$441K	Sell	4,450 -500	-10%	-$48.5K	0.17%	54
2017 Q2	$500K	Hold	4,950	–	–	0.21%	53
2017 Q1	$574K	Buy	4,950 +600	+14%	+$69.7K	0.24%	51
2016 Q4	$522K	Hold	4,350	–	–	0.24%	52
2016 Q3	$487K	Hold	4,350	–	–	0.22%	54
2016 Q2	$539K	Hold	4,350	–	–	0.25%	52
2016 Q1	$487K	Hold	4,350	–	–	0.23%	52
2015 Q4	$474K	Hold	4,350	–	–	0.23%	50
2015 Q3	$435K	Hold	4,350	–	–	0.22%	53
2015 Q2	$496K	Hold	4,350	–	–	0.24%	51
2015 Q1	$452K	Hold	4,350	–	–	0.22%	51
2014 Q4	$522K	Buy	4,350 +150	+4%	+$19.7K	0.25%	50
2014 Q3	$613K	Hold	4,200	–	–	0.31%	47
2014 Q2	$701K	Sell	4,200 -200	-5%	-$35.6K	0.36%	46
2014 Q1	$874K	Buy	4,400 +50	+1%	+$9.44K	0.47%	43
2013 Q4	$831K	Buy	4,350 +50	+1%	+$9.3K	0.45%	45
2013 Q3	$826K	Hold	4,300	–	–	0.46%	43
2013 Q2	$654K	Buy	+4,300	New	+$609K	0.42%	46

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Dillon & Associates's CLB Position: Q4 2018 in Review

Dillon & Associates sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 4,450 shares — an estimated $516K sold.

Dillon & Associates first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $874K in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Dillon & Associates reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Dillon & Associates sold 4,450 Core Laboratories shares in Q4 2018, an estimated $516K.
Dillon & Associates first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
Dillon & Associates's Core Laboratories position peaked at $874K in Q1 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Dillon & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.